Acute hepatitis C virus in an HIV clinic: A screening strategy, risk factors, and perception of risk

AIDS Patient Care and STDs

Volumn 25, Issue 10, 2011, Pages 571-577

  Taylor, L E ^a,c   Delong, A K ^b   Maynard, M A ^c   Chapman, S ^c   Gholam, P ^d   Blackard, J T ^e   Rich, J ^a,c   Mayer, K H ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALANINE AMINOTRANSFERASE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; DARUNAVIR; DIAMORPHINE; EMTRICITABINE; RALTEGRAVIR; RITONAVIR; TENOFOVIR; VIRUS RNA;

ACUTE HEPATITIS; ACUTE HEPATITIS C; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHLAMYDIASIS; COLLEGE; CONTROLLED STUDY; EDUCATIONAL STATUS; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PILOT STUDY; QUESTIONNAIRE; RISK FACTOR; SCREENING; SELF REPORT; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; AMBULATORY CARE FACILITIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; RHODE ISLAND; RISK; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

EID: 80053414215     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0106     Document Type: Article

References (44)

1. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.
2. fisher M RD, Sabin C. Acute hepatitis C in men who have sex with men is not confined to those infected with HIV and their number continues to increase. 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles CA: February 25-28, 2007.
3. Ghosn J, Pierre-Francois S, Thibault V, et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med 2004;5:303-306. (Pubitemid 39077124)
4. Luetkemeyer A, Hare CB, Stansell J, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 2006;41:31-36. (Pubitemid 41786016)
5. Fletcher S. Sexual transmission of hepatitis C and early intervention. J Assoc Nurses AIDS Care 2003;14(5 Suppl):87S-94S. (Pubitemid 38552990)
6. Gilleece YC, Browne RE, Asboe D, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr 2005;40:41-6. (Pubitemid 41233203)
7. Serpaggi J, Chaix ML, Batisse D, et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006;20:233-240.
8. Hagan H, Thiede H, Des Jarlais DC. HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS 2005;19(Suppl 3):S199-207. (Pubitemid 41682188)
9. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med 2006;166:1632-1641. (Pubitemid 44232373)
10. Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007;21:983-991. (Pubitemid 46684329)
11. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: An expanding epidemic. AIDS 2009;23:F1-7.
12. Schmidt AJ, Rockstroh JK, Vogel M, et al. Trouble with bleeding: Risk factors for acute hepatitis C among HIVpositive gay men from Germany-A case-control study. PLoS ONE 2011;6:e17781.
13. Dionne-Odom J, Osborn MK, Radziewicz H, Grakoui A, Workowski K. Acute hepatitis C and HIV coinfection. Lancet Infect Dis 2009;9:775-783.
14. Berenguer J, Alvarez-Pellicer J, Martin PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009;50:407-413.
15. Bruno S, Stroffolini T, Colombo M, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study. Hepatology 2007;45:579-587. (Pubitemid 46453759)
16. SingalAG,VolkML, JensenD, Di BisceglieAM, Schoenfeld PS. A sustained viral response is associated with reduced liverrelated morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol 2010;8:280-288, 288 e281.
17. Matthews GV, Hellard M, Haber P, et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis 2009;48:650-658.
18. Dore GJ, Hellard M, Matthews GV, et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 2010;138:123-135, e121-122.
19. Dominguez S, Ghosn J, Valantin MA, et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS 2006;20:1157-1161. (Pubitemid 43786104)
20. McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 2007;45(Suppl 2):S47-56; discussion S66-47. (Pubitemid 47294916)
21. Torriani F, Rodriguez-Torres M, Rockstroh J, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438-450. (Pubitemid 38988593)
22. Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa- 2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004;292:2839-2848. (Pubitemid 39628231)
23. Chung R, Andersen J, Volberding P, et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004;351:451-459. (Pubitemid 38988594)
24. Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009;23:89-93.
25. Craxi A. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol (in press).
26. Acute hepatitis C in HIV-infected individuals: Recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS 2011;25:399-409.
27. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006;42:75-79. (Pubitemid 43947949)
28. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV- 1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760-768.
29. Hitzler WE, Runkel S. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Transfusion 2001;41:333-337. (Pubitemid 32238530)
30. Linas BW, A; Schackman, B; Kim, A; Freedberg, K. Costeffective Screening for Acute HCV Infection in HIV+ MSM. 18th Conference on Retroviruses and Opportunistic Infections [Paper # 917.]. Vol Session 180 Poster Abstracts. Boston, MA: 2011.
31. Halfon P, Riflet H, Renou C, Quentin Y, Cacoub P. Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol 2001;39:1204-1206. (Pubitemid 32209755)
32. Condotta SA, Hunter FF, Bidochka MJ. West Nile virus infection rates in pooled and individual mosquito samples. Vector Borne Zoonotic Dis 2004;4:198-203. (Pubitemid 39429945)
33. Mayer KH DR, Abbott D, Cavanaugh T, Case P. . Sexual Health Services in a New England Gay Bathhouse: Opportunities for HIV/STD Treatment and Prevention (oral). National HIVPrevention Conference. Atlanta, GA:August 23-26, 2009.
34. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001;50:1-57; quiz CE51-19a51-CE56- 19a51.
35. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003;125:80-88. (Pubitemid 36799109)
36. Brant LJ, Ramsay ME, Balogun MA, et al. Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations. J Viral Hepat 2008;15:871-877.
37. Roche. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus [Media Release]. 2009.
38. DeWeerdt S. Diagnostics: A testing journey. Nature 2011; 474:S20-S21.
39. Hoover K WK, Follansbee S, Gratzer B, Hare B, Johnston B, Chorba T, Kent C. Hepatitis Screening of HIV-infected Men Who Have Sex with Men: 8 US Clinics [Poster Abstract 803]. 16th Conference on Retroviruses and Opportunistic Infections (CROI) 2009. Montreal, Canada: February 8-11, 2009.
40. Kim AA, Kent CK, Klausner JD. Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS 2002;16:1425-1428. (Pubitemid 34722077)
41. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002;97:1289-1294.
42. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005;353:460-467. (Pubitemid 41127290)
43. Rockstroh JK, Bhagani S, Benhamou Y, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008;9:82-88. (Pubitemid 351228130)
44. HooverKW,ButlerM,Workowski K, et al. STDscreening ofHIVinfected MSMin HIV clinics. Sex Transm Dis 2010;37:771-776.